Free Trial
→ Elon’s “New Gold” (From True Market Insiders) (Ad) Free CSCI Stock Alerts

COSCIENS Biopharma (CSCI) SEC Filings & 10K Form

$2.76 +0.03 (+0.91%)
As of 02/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent COSCIENS Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
12/23/2024
6:45 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
5:05 PM		COSCIENS Biopharma Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SCHEDULE 13D/A
10/08/2024
6:30 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
4:29 PM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
6:30 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
1:04 PM		COSCIENS Biopharma Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13D
08/27/2024
6:30 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM		COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
2:36 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
8:20 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
12:31 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
12:46 PM		Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13G
06/04/2024
11:15 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/30/2024
8:55 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:58 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2024
8:31 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K/A
05/17/2024
7:00 AM		Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Form FWP
05/17/2024
7:00 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
11:15 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/01/2024
3:51 PM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2024
9:28 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:00 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:00 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:05 AM		Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CSCI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored